Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 9.728.505.905.995.90

What is the latest EV/Net Sales ratio of TORRENT PHARMACEUTICALS ?

The latest EV/Net Sales ratio of TORRENT PHARMACEUTICALS is 9.72 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20259.72
Mar20248.50
Mar20235.90
Mar20225.99
Mar20215.90

How is EV/Net Sales of TORRENT PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2025 9.72
14.35
Mar2024 8.5
44.07
Mar2023 5.9
-1.50
Mar2022 5.99
1.53
Mar2021 5.9 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹142,459.6 Cr 3.1% 5.9% 39% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics
MANKIND PHARMA ₹85,665.3 Cr -0.2% -2.3% -14.8% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

3.1%

5.9%

39%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses